H.C. Wainwright analyst Kevin Dede reiterated a Buy rating on MTBC Inc (MTBC) today and set a price target of $6.00. The company’s shares closed last Monday at $4.00.
According to TipRanks.com, Dede has 0 stars on 0-5 star ranking scale with an average return of -20.1% and a 28.6% success rate. Dede covers the Consumer Goods sector, focusing on stocks such as The Alkaline Water Company Inc, Microvision, and SuperCom.
Currently, the analyst consensus on MTBC Inc is a Moderate Buy with an average price target of $6.00.
See today’s analyst top recommended stocks >>
Based on MTBC Inc’s latest earnings release for the quarter ending June 30, the company reported a quarterly GAAP net loss of $771K. In comparison, last year the company had a GAAP net loss of $1.83 million.
Based on the recent corporate insider activity of 61 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MTBC in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
MTBC, Inc. is a healthcare information technology company, which engages in the provision of web-based solutions and business services to healthcare providers. It operates through the Healthcare Information Technology (IT) and Practice Management segments. The Healthcare IT segment includes revenue cycle management and other services.
